Fungal identification in the clinical laboratory uses a combination of microscopy, culture, antigen detection, and increasingly molecular methods. Each approach has specific strengths, and the optimal diagnostic strategy depends on the suspected organism and the patient's immune status. Understanding the morphological features used in fungal microscopy, the key culture characteristics, and the clinical utility of fungal biomarkers allows clinicians and laboratory scientists to work together effectively.
The Yeasts: Candida and Cryptococcus
Yeasts are unicellular fungi that reproduce by budding. The most clinically important yeasts are Candida species and Cryptococcus neoformans.
Candida species are the most common cause of invasive fungal infection in hospitals. Most candidal infections begin as a complication of Candida colonisation of gut or skin being allowed to penetrate tissue barriers through IV catheters, gut surgery, or broad-spectrum antibiotic disruption of the normal bacterial microbiome.
Species identification matters clinically:
C. albicans: most common, almost always susceptible to fluconazole.
C. glabrata (now Nakaseomyces glabrata): inherently less susceptible to fluconazole, step-up resistance common. Increasingly important in elderly patients.
C. krusei (now Pichia kudriavzevii): intrinsically resistant to fluconazole.
C. parapsilosis: susceptible to fluconazole, common in NICU and catheter-associated infections.
C. tropicalis: often susceptible, common in neutropenic haematology patients.
C. auris: emerging globally, multidrug-resistant (resistant to fluconazole and often echinocandins and amphotericin B), causes persistent outbreaks in ICU settings, requires enhanced infection control.
On Gram stain: Candida appears as oval budding yeast cells (3 to 6 micrometres). Many species produce pseudohyphae (chains of elongated cells) or true hyphae when invading tissue. C. albicans produces germ tubes (true hyphae extending from the yeast cell without a constriction at the origin) when incubated in serum at 37 degrees Celsius for 2 to 3 hours: the germ tube test is a rapid same-day presumptive identification for C. albicans.
Chromogenic Candida agar: different Candida species produce distinct colony colours on chromogenic media, allowing rapid species presumptive identification: C. albicans (green), C. tropicalis (blue), C. krusei (pink, rough). MALDI-TOF identifies Candida species from colonies in minutes.
Cryptococcus neoformans causes cryptococcal meningitis in patients with advanced HIV (CD4 below 100) and in solid organ transplant recipients. The organism has a large polysaccharide capsule that appears as a clear halo around the yeast cell on India ink preparation of CSF (India ink negative stain: the capsule excludes ink, creating a bright halo around the dark-background yeast cell). Cryptococcal antigen (CrAg) lateral flow assay (LFA) from serum or CSF is highly sensitive (above 99 per cent) and specific (above 99 per cent) for cryptococcal infection and is the primary diagnostic tool, with same-day results.
The Moulds: Aspergillus, Mucorales, and Others
Moulds are multicellular fungi composed of branching filaments called hyphae. The colony grows as a mycelium (a mass of hyphae). Spores (conidia in Aspergillus) are the infectious units inhaled from the environment.
Aspergillus fumigatus is the most common cause of invasive mould infection in immunocompromised patients, particularly those with prolonged neutropenia (haematological malignancy, HSCT) or long-term high-dose corticosteroids (solid organ transplant, autoimmune disease). Invasive pulmonary aspergillosis (IPA) is the most common manifestation.
Microscopy: Aspergillus hyphae are hyaline (clear, non-pigmented), septate (have cross-walls), and branch at 45-degree angles, giving a distinctive branching appearance in tissue sections (Grocott methenamine silver stain). This 45-degree branching at acute angles (compared to 90-degree branching in Mucorales) is the key microscopic distinction.
Culture: A. fumigatus grows rapidly (2 to 5 days) on Sabouraud dextrose agar, producing a blue-green to dark green powdery colony. Microscopy of the colony shows characteristic conidiophores with flask-shaped vesicles and chains of conidia (phialides arranged in a brush-like structure).
Galactomannan (GM) antigen: Aspergillus cell wall polysaccharide released during invasive infection. Detected by Platelia Aspergillus EIA (sandwich ELISA) from serum or BAL. BAL GM has sensitivity of approximately 75 to 90 per cent and specificity of approximately 85 to 95 per cent for IPA in haematological malignancy patients. Used as primary diagnostic biomarker and for monitoring treatment response.
Aspergillus PCR: highly sensitive (above 88 per cent from BAL), available from serum and BAL. Increasingly used in combination with GM for diagnosis and monitoring.
Mucorales (Mucormycosis): Mucorales include Rhizopus, Mucor, Lichtheimia (Absidia), and Cunninghamella. Mucormycosis is the second most common invasive mould infection and has very high mortality (50 to 100 per cent for disseminated disease). Key risk factors: uncontrolled diabetes mellitus (particularly DKA, where iron is released from transferrin in the acid pH, providing a growth factor), deferoxamine therapy (which supplies iron as a siderophore substrate for Mucorales), prolonged neutropenia, and solid organ transplant.
Microscopy distinguishes Mucorales from Aspergillus: Mucorales hyphae are pauciseptate (few or no cross-walls), ribbon-like, and branch at 90-degree angles. This distinction is critical as treatment differs: voriconazole (first-line for Aspergillus) has no activity against Mucorales. Mucormycosis requires liposomal amphotericin B plus surgical debridement.
Antifungal Susceptibility and Resistance
The four main classes of antifungal drugs:
Azoles (fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole): inhibit ergosterol synthesis by blocking lanosterol demethylase (CYP51). C. krusei and C. auris are intrinsically resistant. Azole resistance in A. fumigatus is increasing due to environmental exposure to triazole fungicides in agriculture, with prevalence above 10 per cent in some European countries.
Echinocandins (caspofungin, micafungin, anidulafungin): inhibit beta-1,3-glucan synthase, disrupting the fungal cell wall (humans lack this enzyme: selective toxicity). First-line for invasive candidiasis. C. parapsilosis has intrinsically elevated echinocandin MICs. Echinocandin resistance in C. auris is emerging.
Polyenes (amphotericin B, liposomal amphotericin B): bind ergosterol in the fungal cell membrane, forming pores. Broad-spectrum: active against most yeasts and moulds. Liposomal formulation has lower nephrotoxicity. First-line for Mucormycosis.
Flucytosine (5-FC): converted intracellularly to 5-fluorouracil, inhibiting DNA synthesis. Used in combination with amphotericin B for cryptococcal meningitis (synergistic, reduces relapse rate). Not used as monotherapy due to rapid resistance development.
Frequently Asked Questions
What is the germ tube test for Candida?
The germ tube test is a rapid presumptive test for C. albicans identification. A colony is suspended in human serum and incubated at 37 degrees Celsius for 2 to 3 hours. C. albicans (and C. dubliniensis) produce germ tubes: true hyphae extending from the yeast cell without a constriction at the origin. A positive result is presumptive for C. albicans. Other Candida species do not produce germ tubes in this timeframe under these conditions.
What is galactomannan and how is it used?
Galactomannan is a polysaccharide component of the Aspergillus cell wall released into blood and body fluids during invasive infection. It is detected by sandwich ELISA (Platelia Aspergillus) or lateral flow assay. BAL galactomannan has sensitivity of 75 to 90 per cent and specificity of 85 to 95 per cent for invasive pulmonary aspergillosis in haematological malignancy patients. It is used as a primary diagnostic biomarker and for treatment monitoring (falling GM indicates response, rising GM indicates failure or breakthrough infection).
What is Candida auris and why is it a concern?
Candida auris is an emerging multidrug-resistant yeast that emerged globally after 2012. It is frequently resistant to fluconazole and may be resistant to echinocandins and amphotericin B, leaving very limited treatment options. It causes outbreaks in ICUs because it survives on environmental surfaces for prolonged periods. Infection control for C. auris requires contact precautions, enhanced environmental decontamination with chlorine-based products (not quaternary ammonium compounds), and screening of ICU contacts.
How do you distinguish Aspergillus from Mucorales in tissue?
The critical microscopic distinction: Aspergillus hyphae are narrow (3 to 6 micrometres), septate (have regular cross-walls), and branch at acute (45-degree) angles. Mucorales hyphae are broad (10 to 20 micrometres), pauciseptate (ribbon-like, few cross-walls), and branch at right angles (90 degrees). This distinction is clinically critical because voriconazole (first-line for aspergillosis) has no activity against Mucorales, which require liposomal amphotericin B.
What is cryptococcal meningitis?
Cryptococcal meningitis is a life-threatening fungal meningitis caused by Cryptococcus neoformans (predominantly) in immunocompromised patients, particularly HIV-positive individuals with CD4 below 100 cells/microlitre. It presents with subacute onset of headache, meningism, fever, and raised intracranial pressure (which must be managed by serial lumbar puncture or lumbar drain). Diagnosis: India ink of CSF, cryptococcal antigen (CrAg) from CSF or serum (lateral flow assay, sensitivity above 99 per cent), CSF culture. Treatment: amphotericin B plus flucytosine induction, followed by fluconazole consolidation and maintenance.
What is India ink used for in mycology?
India ink is a negative stain used to visualise the polysaccharide capsule of Cryptococcus neoformans in CSF. The ink fills the background but is excluded by the capsule, producing a clear halo around each yeast cell against the dark background. It provides a rapid same-day presumptive diagnosis of cryptococcal meningitis from CSF with a sensitivity of approximately 60 to 80 per cent in HIV-associated meningitis.
What antifungals cover Mucorales?
Liposomal amphotericin B is the primary treatment for mucormycosis. Isavuconazole has demonstrated activity and regulatory approval for mucormycosis in some settings. Voriconazole and other triazoles have no activity against Mucorales. Echinocandins have no activity against Mucorales. Surgical debridement of infected tissue is an essential component of mucormycosis treatment alongside antifungal therapy.
What is Pneumocystis jirovecii and is it a fungus?
Pneumocystis jirovecii (formerly P. carinii) is a fungus (reclassified from protozoon based on ribosomal RNA sequencing in the 1980s), but it behaves very differently from most fungi: it cannot be grown in standard culture, it is not susceptible to most antifungal drugs (amphotericin B is inactive), and it is specifically treated with high-dose co-trimoxazole (trimethoprim-sulfamethoxazole). Diagnosis is by microscopy of respiratory samples (Grocott stain, calcofluor white, PCR). It causes PCP (Pneumocystis jirovecii pneumonia) in immunocompromised patients.
What is Aspergillus galactomannan index?
The galactomannan optical density index (ODI) is the ratio of the sample optical density to the mean positive control optical density in the Platelia Aspergillus EIA. An ODI of 0.5 or above on two consecutive serum samples, or an ODI of 1.0 or above on a single BAL sample, meets EORTC/MSG diagnostic criteria for probable IPA in appropriate clinical contexts. Rising ODI on sequential testing in a patient on antifungal therapy indicates treatment failure.
Why is early diagnosis of IFI so important?
Invasive fungal infections, particularly IPA and mucormycosis, have mortality rates that increase dramatically with each day of delay in diagnosis and treatment. In haematological malignancy patients, IPA mortality exceeds 50 per cent without antifungal therapy and falls to 20 to 30 per cent with early treatment. Early diagnosis — using GM, beta-D-glucan, CT thorax (halo sign in IPA), and PCR — allows antifungal treatment to start before the full extent of infection is established.